Ion Channel Gene Expression in Lung Adenocarcinoma: Potential Role in Prognosis and Diagnosis

Ion channels are known to regulate cancer processes at all stages. The roles of ion channels in cancer pathology are extremely diverse. We systematically analyzed the expression patterns of ion channel genes in lung adenocarcinoma. First, we compared the expression of ion channel genes between normal and tumor tissues in patients with lung adenocarcinoma. Thirty-seven ion channel genes were identified as being differentially expressed between the two groups. Next, we investigated the prognostic power of ion channel genes in lung adenocarcinoma. We assigned a risk score to each lung adenocarcinoma patient based on the expression of the differentially expressed ion channel genes. We demonstrated that the risk score effectively predicted overall survival and recurrence-free survival in lung adenocarcinoma. We also found that the risk scores for ever-smokers were higher than those for never-smokers. Multivariate analysis indicated that the risk score was a significant prognostic factor for survival, which is independent of patient age, gender, stage, smoking history, Myc level, and EGFR/KRAS/ALK gene mutation status. Finally, we investigated the difference in ion channel gene expression between the two major subtypes of non-small cell lung cancer: adenocarcinoma and squamous-cell carcinoma. Thirty ion channel genes were identified as being differentially expressed between the two groups. We suggest that ion channel gene expression can be used to improve the subtype classification in non-small cell lung cancer at the molecular level. The findings in this study have been validated in several independent lung cancer cohorts.

[1]  G. Santoni,et al.  TRPV channels in tumor growth and progression. , 2011, Advances in experimental medicine and biology.

[2]  J. Minna,et al.  Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Luc Girard,et al.  Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. , 2007, Cancer research.

[4]  L. Jan,et al.  Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Chuhsing Kate Hsiao,et al.  Identification of a Novel Biomarker, SEMA5A, for Non–Small Cell Lung Carcinoma in Nonsmoking Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[6]  Juan Zhou,et al.  Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+. , 2008, Life sciences.

[7]  G. Barritt,et al.  TRP channels in cancer. , 2007, Biochimica et biophysica acta.

[8]  K. Kunzelmann Ion Channels and Cancer , 2005, The Journal of Membrane Biology.

[9]  L. Holmberg,et al.  Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  D. Khaitan,et al.  Role of KCNMA1 gene in breast cancer invasion and metastasis to brain , 2009, BMC Cancer.

[11]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[12]  E. Wieben,et al.  Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. , 1992, Mayo Clinic proceedings.

[13]  H. Sevestre,et al.  Intermediate conductance Ca2+ activated K+ channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status. , 2010, Histology and histopathology.

[14]  N. Girard,et al.  New driver mutations in non-small-cell lung cancer. , 2011, The Lancet. Oncology.

[15]  F. Wrba,et al.  The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. , 2000, The American journal of pathology.

[16]  Y. Gruel,et al.  Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. , 2007, The international journal of biochemistry & cell biology.

[17]  Jaime Prilusky,et al.  GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support , 1998, Bioinform..

[18]  J. A. Peters,et al.  Transient receptor potential cation channels in disease. , 2007, Physiological reviews.

[19]  Nam Huh,et al.  Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression , 2008, Clinical Cancer Research.

[20]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[21]  Mansoor Abdul,et al.  Activity of potassium channel-blockers in breast cancer. , 2003, Anticancer research.

[22]  David Venet,et al.  Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..

[23]  G. Santoni,et al.  Expression of transient receptor potential vanilloid‐1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters , 2010, Histopathology.

[24]  P. Dasgupta,et al.  Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. , 2008, Trends in pharmacological sciences.

[25]  L. Ricci-Vitiani,et al.  TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner. , 2010, Carcinogenesis.

[26]  O. Crociani,et al.  Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. , 2009, Current medicinal chemistry.

[27]  A. G. Cooper,et al.  Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis. , 2001, Cancer research.

[28]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[29]  V. Firlej,et al.  Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. , 2010, Cancer research.

[30]  T. Jentsch,et al.  Ion channels: Function unravelled by dysfunction , 2004, Nature Cell Biology.

[31]  D. Lancet,et al.  GeneCards: integrating information about genes, proteins and diseases. , 1997, Trends in genetics : TIG.

[32]  R. Kurzrock,et al.  Targeted therapy in non-small-cell lung cancer—is it becoming a reality? , 2011, Nature Reviews Clinical Oncology.

[33]  G. Santoni,et al.  TRP channels and cancer: new targets for diagnosis and chemotherapy. , 2011, Endocrine, metabolic & immune disorders drug targets.

[34]  D. Green,et al.  c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells , 2012, Cell.

[35]  R. Sikes,et al.  Voltage-sensitive ion channels and cancer , 2006, Cancer and Metastasis Reviews.

[36]  M. Wigler,et al.  Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. , 2003, Cancer cell.

[37]  Puthen V. Jithesh,et al.  Gene Expression Meta-Analysis Identifies VDAC1 as a Predictor of Poor Outcome in Early Stage Non-Small Cell Lung Cancer , 2011, PloS one.

[38]  Satoru Miyano,et al.  Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. , 2012, Cancer research.

[39]  H. Schuller Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.

[40]  S. Wacholder,et al.  Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.

[41]  S. Scheuring,et al.  Supramolecular assembly of VDAC in native mitochondrial outer membranes. , 2007, Journal of molecular biology.

[42]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[43]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[44]  C. Stock,et al.  Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. , 2013, Cancer research.

[45]  N. Prevarskaya,et al.  Oncogenic TRP channels. , 2011, Advances in experimental medicine and biology.

[46]  T. Bíró,et al.  Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma , 2009, Journal of Cancer Research and Clinical Oncology.

[47]  N. Prevarskaya,et al.  Ion channels and the hallmarks of cancer. , 2010, Trends in molecular medicine.